ImmunoQure AG

ImmunoQure AG is a young biotech company spearheading the research & development of human-derived autoantibodies for the treatment of human diseases. We are an international group of researchers and entrepreneurs with a common goal: to create a new generation of drugs for the treatment of human diseases. ImmunoQure has a network of collaborations with industrial and academic partners that enable the development of our autoantibody-based drugs. Through our unique access to rare patient populations, we are able to correlate clinical status with serological profiles and subsequently clone autoantibodies which the patient’s own immune system has optimized against key drug targets involved in preventing a number of human diseases.